The UK-based announced it had leased a 30,000 square foot building at the Babraham Research Campus in Cambridge in the UK in 2015.
Last week the firm announced it is relocating all its UK operations including the head office functions, biology and chemistry research services groups.
In the US, Abzena has leased a 50,000 foot facility at Lusk Boulevard, San Diego at which it plans to consolidate its regional operations.
The project will see Abzena relocate activities carried out at a leased laboratory in Torrey Pines, which it took on when it bought Pacific GMP in 2015.
The Lusk Boulevard facility houses clean rooms that will accommodate 500L and 2,000L bioreactors operated by Abzena’s manufacturing division.
On January 4, the firm entered into a preferred biomanufacturing equipment supply and services agreement with Sartorius Stedim Biotech SA.
Under the deal, Sartorius will supply the bioprocess reactor equipment, process analytic software and to provide support for the design of the facility. The site is expected to be fully operation in early 2019.